Rivastigmine mini-tablet for Alzheimer's disease
Part of Brain & nervous system clinical trials.
This trial tests a smaller, easier-to-swallow version of rivastigmine for people with Alzheimer's disease. It looks at whether the mini-tablet can help with memory and thinking symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 50 or older
- Diagnosed with probable Alzheimer's disease based on standard clinical criteria
- Score between 10 and 24 on a memory and thinking test (MMSE) at the start of the study
- No signs of major depression or other serious mental health conditions
- Brain MRI shows no recent strokes or significant damage in key memory areas
- A family member or friend who knows your condition well and can help with the study
- No use of Alzheimer's medications in the two weeks before starting the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a rotigotine patch to your usual rivastigmine treatment can help with symptoms of Alzheimer's. It is for people with mild to moderate Alzheimer's who have been stable on rivastigmine for at least 3 months.
This study tests whether Huperzine A controlled-release tablets can help improve memory and thinking in people with mild-to-moderate Alzheimer's disease. You'll take the tablets or a placebo to see if it slows down dementia symptoms.
This Phase 2 trial tests an oral medicine (EX039) to see if it can help people with mild Alzheimer’s disease. It focuses on slowing or improving thinking and memory problems over time.
This trial compares donepezil (a medicine for Alzheimer’s symptoms) against a non-drug treatment plan. It aims to see which approach helps people with Alzheimer’s who still have measurable thinking ability and specific Alzheimer’s test results.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
This study tests an experimental medication called RO7568282 to see if it can slow down memory decline in people with early Alzheimer's disease. If you have early memory problems and a confirmed Alzheimer's-related brain change, you may be able to join.
Hear when a new Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.